Auna S.A. (NYSE: AUNA) shareholders back AGM items as Board shifts to seven members

Rhea-AI Filing Summary

Auna S.A. reported the results of its annual general meeting, where shareholders approved all matters presented to them. The company also updated its board structure, setting the board at seven members after Jorge Basadre and Guadalupe Phillips stepped down, with the vacancies not being filled for now. Following these changes, the board still has a majority of independent directors. As of March 31, 2026, Auna’s Latin American healthcare platform included 31 facilities with 2,337 beds and 1.4 million health plan members.

Key Figures

Healthcare facilities: 31 facilities Bed capacity: 2,337 beds Health plan members: 1.4 million members +1 more

4 metrics

Healthcare facilities 31 facilities Auna network size as of March 31, 2026

Bed capacity 2,337 beds Total beds across Auna facilities as of March 31, 2026

Health plan members 1.4 million members Auna health plans as of March 31, 2026

Board size 7 directors Board determined seven-member structure, effective July 2026

Key Terms

Annual General Meeting, independent directors, horizontally integrated network, vertically integrated portfolio, +1 more

5 terms

Annual General Meeting regulatory

"announced today the results of its annual general meeting of shareholders"

independent directors regulatory

"Following these changes, the Board continues to have a majority of independent directors."

Members of a company’s board who do not have significant business, family, or financial ties to the company and are not part of its management; they are chosen to provide impartial oversight of strategy, financial reporting, executive pay and risk. They matter to investors because independent directors act like an objective referee, helping ensure decisions favor shareholders’ long-term interests rather than insiders, which can strengthen trust and reduce the chance of mismanagement or conflicts of interest.

horizontally integrated network financial

"consisting of a horizontally integrated network of medical care centers"

vertically integrated portfolio financial

"and a vertically integrated portfolio of oncology and general health plans."

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 07/07/2026 - 05:16 PM Accepted by SEC EDGAR 07/07/2026 - 05:16 PM Learn about SEC filing dates

FAQ

What did Auna S.A. shareholders approve at the 2026 Annual General Meeting?

Shareholders approved and adopted all matters submitted at Auna S.A.’s June 30, 2026 Annual General Meeting. The filing does not list each item, but confirms full approval of the agenda presented to shareholders by the company.

How did Auna S.A. change its Board composition in July 2026?

Auna S.A. set its Board size at seven members and announced that Jorge Basadre and Guadalupe Phillips stepped down effective July 6, 2026. The Board does not currently plan to fill the resulting vacancies, yet maintains a majority of independent directors.

Does Auna S.A. still have a majority of independent directors after the Board changes?

Yes, Auna S.A. states that its Board continues to have a majority of independent directors after reducing the Board to seven members. This indicates that most directors meet independence criteria while the two vacated seats remain unfilled for now.

What is the scale of Auna S.A.’s healthcare network as of March 31, 2026?

As of March 31, 2026, Auna S.A.’s platform comprised 31 healthcare facilities across Mexico, Peru, and Colombia. These hospitals, ambulatory, and wellness centers provided 2,337 beds and supported 1.4 million health plan members within its integrated healthcare offering.

In which countries does Auna S.A. operate its healthcare platform?

Auna S.A. operates its integrated healthcare platform in Mexico, Peru, and Colombia. The company focuses on prevention and complex diseases in low-penetration markets across Spanish-speaking Latin America, combining medical care centers with oncology and general health plan offerings.

What type of healthcare services does Auna S.A. focus on?

Auna S.A. prioritizes preventive care and complex diseases that drive the highest healthcare spending. It runs a horizontally integrated network of care facilities and a vertically integrated portfolio of oncology and general health plans across Spanish-speaking Latin American markets.

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File Number: 001-41982

Auna S.A.

(Exact name of registrant as specified in its charter)

‎ 6, rue Jean Monnet

L-2180 Luxembourg

Grand Duchy of Luxembourg

‎+51 1-205-3500‎

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

TABLE OF CONTENTS

EXHIBIT
99.1	Auna Announces Results of Annual General Meeting and Board Composition Update

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Auna S.A.
	By:	/s/ Gisele Remy
		Name:	Gisele Remy
		Title:	Chief Financial Officer

Date: July 7, 2026

Exhibit 99.1

 

Auna Announces Results of Annual General Meeting and Board Composition Update

Luxembourg– July 7, 2026 - Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the results of its annual general meeting of shareholders held on June 30, 2026 (the “Annual General Meeting”). The Company’s shareholders approved and adopted all of the matters submitted to them, as described below.

1. Convening formalities. The shareholders confirmed that the Annual General Meeting had been duly convened and validly constituted.

2. Confirmation of share awards to independent directors. The shareholders confirmed the share awards granted to the independent directors, as approved by the board of directors of the Company (the “Board”), with the directors concerned having abstained under Article 441-7 of the Luxembourg law of August 10, 1915 on commercial companies, as amended.

3. Approval of the 2025 reports, accounts and allocation of the result. The shareholders approved the Board’s management reports and the reports of the statutory auditor of the Company (the “Statutory Auditor”) and the contractual auditor for the financial year ended December 31, 2025 (the “2025 Financial Year”); approved the Company’s separate annual accounts and its consolidated financial statements prepared for Luxembourg regulatory purposes and for the information of investors; and resolved on the allocation of the result for the 2025 Financial Year as proposed by the Board.

4. Discharge to the directors. The shareholders granted discharge to the directors for the performance of their mandate for the 2025 Financial Year.

5. Discharge and reappointment of the Statutory Auditor. The shareholders granted discharge to the Statutory Auditor for the 2025 Financial Year and reappointed it for the financial year ending December 31, 2026, until the annual general meeting to be held in 2027.

6. Ratification of remuneration and compensation. The shareholders ratified the directors’ remuneration and the compensation granted to certain directors by the Compensation and Talent Committee and approved by the Board for the 2025 Financial Year.

7. Miscellaneous. No other business was transacted at the Annual General Meeting.

Board Composition Update

Separately, the Board has determined that a seven-member Board is appropriate for Auna at this time. Accordingly, Jorge Basadre and Guadalupe Phillips have stepped down from the Board, effective July 6, 2026. The Board does not intend, at this time, to fill the resulting vacancies.

Following these changes, the Board continues to have a majority of independent directors.

The Board and management team thank Jorge and Guadalupe for their service and contributions to Auna during an important period for the Company and wish them continued success in their future endeavors.

About Auna

Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of March 31, 2026, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,337 beds and 1.4 million health plan members.

For more information visit www.aunainvestors.com

Investor Relations Contact contact@aunainvestors.com

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 14.6 KB